| 1 |
35447544 | Histamine H3 receptor antagonists - Roles in neurological and endocrine diseases and diabetes mellitus. | 2022 Jun |
1 |
| 2 |
28465562 | Activation of the ileal neuroendocrine tumor cell line P-STS by acetylcholine is amplified by histamine: role of H3R and H4R. | 2017 May 2 |
1 |
| 3 |
23000530 | Therapeutic potential of histaminergic compounds in the treatment of addiction and drug-related cognitive disorders. | 2013 Jan 15 |
1 |
| 4 |
22267207 | Computational analysis of novel drugs designed for use as acetylcholinesterase inhibitors and histamine H3 receptor antagonists for Alzheimer's disease by docking, scoring and de novo evolution. | 2012 Apr |
2 |
| 5 |
18673168 | Histamine H3 antagonists as wake-promoting and pro-cognitive agents. | 2008 |
1 |
| 6 |
20144064 | Recent advances in the development of histamine H3 antagonists. | 2007 Jun |
1 |
| 7 |
16364652 | Discovery of histamine H3 receptor antagonistic property of simple imidazole-free derivatives: Preliminary pharmacological investigation. | 2006 Mar |
1 |
| 8 |
20641888 | 11C-Labeled 6-[(3-cyclobutyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)oxy]-N-methyl-3-pyridinecarboxamide hydrochloride | 2004 |
2 |
| 9 |
23035305 | [18F]-Labeled (R)-(2-(2-(2-methylpyrrolidin-1-yl)ethyl)benzofuran-5-yl)(4-fluorophenyl)-methanone | 2004 |
1 |
| 10 |
10347254 | Cloning and functional expression of the human histamine H3 receptor. | 1999 Jun |
1 |